Glucocorticoids improve the balance of M1/M2 macrophage polarization in experimental autoimmune uveitis through the P38MAPK-MEF2C axis
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110392 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Ruyi Qu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shandong University of Traditional Chinese Medicine, Jinan 250002, China. Hauptthemen laut MEDLINE: Autoimmune Diseases, Uveitis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Uveitis is a common ocular disease that can induce serious complications and sequelae. It is one of the major causes of blindness. Currently, mounting evidence suggests that glucocorticoids (GCs) can suppress ocular inflammation and promote the healing of damaged ocular tissues, but the underlying mechanism remains unclear. The present study aimed to elucidate the mechanism by which GCs modulate the homeostasis of M1/M2 macrophage polarization in experimental autoimmune uveitis (EAU) through the p38MAPK-MEF2C axis. Female Lewis rats were randomly divided into four groups: a normal control (NC) group, an EAU group, an EAU + glucocorticoid (EAU + GC) group, and an EAU + p38MAPK inhibitor (EAU + SB) group. The EAU model was induced in EAU, EAU + GC, and EAU + SB groups, followed by the treatments of normal saline, GC (predisione), and SB203580, respectively. The findings demonstrated that the rats in GC and SB groups had much less ocular inflammation, and the clinical and pathological scores decreased. Further research revealed that GC and SB treatment could inhibit iNOS and CD86 expression while promoting Arg-1 and CD206 secretion in IRBP-induced uveitis rats. Moreover, we found that the role of GC was similar to the results of SB203580, but the role of GC was masked by the C16-PAF (a p38MAPK activator) treatment. Molecular docking and western blot results confirmed that GC's therapeutic action against EAU is mediated via the p38MAPK-MEF2C axis. It regulates macrophage polarization by encouraging M1 to M2 transition and releasing anti-inflammatory factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong University of Traditional Chinese Medicine, Jinan 250002, China.
- The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250002, China.
- Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250002, China.
- Shandong Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Therapy of Ocular Diseases, Shandong Academy of Eye Disease Prevention and Therapy, Medical College of Optomet…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Qu, R., Zhou, M., Qiu, Y., Peng, Y., Yin, X., Liu, B., Bi, H., Gao, Y., & Guo, D. (2023). Glucocorticoids improve the balance of M1/M2 macrophage polarization in experimental autoimmune uveitis through the P38MAPK-MEF2C axis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110392
Vancouver
Qu R, Zhou M, Qiu Y, Peng Y, Yin X, Liu B, et al. Glucocorticoids improve the balance of M1/M2 macrophage polarization in experimental autoimmune uveitis through the P38MAPK-MEF2C axis. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110392
BibTeX
@article{Qu2023,
author = {Qu, Ruyi and Zhou, Mengxian and Qiu, Yan and Peng, Yuan and Yin, Xuewei and Liu, Bin and Bi, Hongsheng and Gao, Yan'e and Guo, Dadong},
title = {Glucocorticoids improve the balance of M1/M2 macrophage polarization in experimental autoimmune uveitis through the P38MAPK-MEF2C axis},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110392}
}
EUVIMED